Latest Developments in Global Saphenous Vein Grafts Market

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Buy Now Buy Now Inquire Before Buying Inquire Before Free Sample Report Free Sample Report

Latest Developments in Global Saphenous Vein Grafts Market

  • Healthcare
  • Upcoming Report
  • Dec 2024
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

  • In February 2021, Aesculap, Inc. completed the asset acquisition of Dextera Surgical Inc. Through this acquisition, Aesculap expanded its product portfolio by adding innovative MicroCutter 5/80 staplers, PAS-Port proximal anastomosis system and innovative devices for CABG surgery to its existing medical devices which contributed in the company’s growth in the cardiothoracic surgery market which is expected to impel the global CABG market growth throughout the forecast period

Frequently Asked Questions

The market is segmented based on Segmentation, By Applications (Coronary Artery Bypass Grafting (CABG), Arteriovenous (AV) Fistulas Access, Vascular Reconstruction), End User (Hospitals, Ambulatory Surgical Centers, Others) – Industry Trends and Forecast to 2032 .
The Global Saphenous Vein Grafts Market size was valued at USD 1.97 USD Billion in 2024.
The Global Saphenous Vein Grafts Market is projected to grow at a CAGR of 5.4% during the forecast period of 2025 to 2032.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America..